365 related articles for article (PubMed ID: 6798422)
1. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
Gehler J
Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
3. Basic findings and current developments in sphingolipidoses.
Pilz H; Heipertz R; Seidel D
Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
[TBL] [Abstract][Full Text] [Related]
4. [Procedure for the diagnosis of sphingolipidoses or allied diseases in adult patients with neurological or psychiatric symptoms (author's transl)].
Pilz H; Heipertz R; Seidel D
Nervenarzt; 1979 Dec; 50(12):749-61. PubMed ID: 94938
[No Abstract] [Full Text] [Related]
5. Lysosomal storage diseases.
Glew RH; Basu A; Prence EM; Remaley AT
Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
[No Abstract] [Full Text] [Related]
6. Enzymatic abnormalities in diseases of sphingolipid metabolism.
Brady RO
Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
[No Abstract] [Full Text] [Related]
7. Inherited neuropathies related to disorders of lipid metabolism.
Thomas PK
Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
[No Abstract] [Full Text] [Related]
8. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
9. Genetic disorders of lysosomes.
Hirschhorn R; Weissmann G
Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
[No Abstract] [Full Text] [Related]
10. [Peripheral nerve involvement in congenital metabolic disorders (author's transl)].
Nonaka I
No To Shinkei; 1979 May; 31(5):445-54. PubMed ID: 90516
[No Abstract] [Full Text] [Related]
11. [Macula findings in thesaurismoses].
François J
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1975; (73):223-65. PubMed ID: 54161
[No Abstract] [Full Text] [Related]
12. Inherited lipid storage diseases of the central nervous system.
Percy AK; Shapiro LJ; Kaback MM
Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
[No Abstract] [Full Text] [Related]
13. [Hereditary diseases related to a disorder in the breakdown of carbohydrate-containing compounds].
Vidershaĭn GIa
Usp Sovrem Biol; 1974; 77(3):434-51. PubMed ID: 4278594
[No Abstract] [Full Text] [Related]
14. Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.
Takahashi K; Naito M
Acta Pathol Jpn; 1985 Mar; 35(2):385-408. PubMed ID: 2992227
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
Philippart M
Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
[TBL] [Abstract][Full Text] [Related]
16. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.
Chen X; Qiu W; Ye J; Han L; Gu X; Zhang H
J Hum Genet; 2016 Apr; 61(4):345-9. PubMed ID: 26740238
[TBL] [Abstract][Full Text] [Related]
17. Progress in investigations of sphingolipidoses.
Adachi M; Schneck L; Volk BW
Acta Neuropathol; 1978 Aug; 43(1-2):1-18. PubMed ID: 97916
[No Abstract] [Full Text] [Related]
18. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
Brady RO; James SP; Barranger JA
Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
[No Abstract] [Full Text] [Related]
19. [Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)].
Pilz H; Heipertz R; Seidel D
Fortschr Neurol Psychiatr Grenzgeb; 1978 Apr; 46(4):207-21. PubMed ID: 417009
[TBL] [Abstract][Full Text] [Related]
20. [Heterogeneity of inborn glycolipidoses and glycoproteinoses and their enzymologic diagnosis].
Tsvetkova IV
Vopr Med Khim; 1982; 28(3):32-41. PubMed ID: 6808764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
